Symptoms and Disease Progression in NEDAMSS

While every child’s journey with NEDAMSS is unique, the disorder often follows a pattern of “regression”—a period of seemingly typical development followed by a loss of skills ^[1]. This progression can be difficult for families, as it often feels as though the child is moving backward. Understanding the typical symptoms and the broad “spectrum” of how this condition appears can help you prepare for the road ahead, but it is critical to remember that these descriptions cannot predict your individual child’s trajectory, and not every child develops every listed feature.

The Typical Sequence: Regression and Loss of Skills

For many children, the first few years of life appear relatively normal. They may sit, crawl, and say their first words on a typical schedule ^[1]. However, this is usually followed by a significant shift:

• Early Infancy: In some severe cases, hypotonia (low muscle tone or “floppiness”) is present from birth or shortly after ^[2].
• The Plateau and Regression: Between early childhood and adolescence, a child may stop gaining new skills (a plateau) and then begin to lose them. This global neurologic regression often starts with a decline in speech and fine motor skills ^[1][3].
• Loss of Speech: Many children eventually lose the ability to speak (loss of speech), transitioning from full sentences to single words, and sometimes to non-verbal communication ^[1].
• Seizure Onset: Epilepsy is a core feature of NEDAMSS. While seizures can start at any time, they often become prominent during or after the period of regression ^[1]. These can range from infantile epileptic spasms syndrome (subtle brief flexion or extension of the trunk or head drops) to drug-resistant epilepsy ^[2][4].

Movement Disorders in NEDAMSS

As the disorder progresses, the way a child moves often changes. These symptoms are caused by the brain’s difficulty in controlling muscle signals:

• Ataxia: A lack of coordination or balance that can make walking look unsteady, wide-based, or poorly coordinated. Over time, this may lead to a loss of the ability to walk independently ^[1][5].
• Dystonia: Involuntary muscle contractions that cause repetitive or twisting movements. This can lead to unusual postures that may be painful or interfere with daily activities ^[6][7].
• Spasticity: Stiffness or tightness in the muscles that can limit the range of motion in the arms or legs ^[3].
• Myoclonus: Sudden, brief, shock-like muscle jerks. In some older patients, this presents as progressive myoclonus epilepsy, where these jerks are triggered by light or sudden movement ^[3].

Variability: Early-Onset vs. Late-Onset

The timing and severity of NEDAMSS are highly variable and often depend on the specific type of change in the IRF2BPL gene ^[8][6].

• Severe Early-Onset: These children may have symptoms starting in the first months of life, including severe hypotonia and early-onset seizures. Suspected spasms require urgent same-day neurologic assessment. When combined with developmental arrest and specific EEG patterns, this may evolve into West syndrome ^[2].
• Later-Onset (Adolescent/Adult): Some individuals do not show significant signs until late childhood or even adulthood. These cases may be characterized by cerebellar ataxia (balance issues) and cognitive impairment that develops much more slowly ^[3][5].

Other Potential Symptoms

Beyond motor and seizure symptoms, NEDAMSS can affect other aspects of health:

• Dysphagia: Difficulty swallowing is common as muscle control declines. This can lead to choking or a risk of food entering the lungs (aspiration) ^[3][9].
• Psychiatric Symptoms: Some individuals in published cohorts have experienced psychiatric challenges, including catatonia (a state where a person may become unresponsive or have unusual, fixed postures) ^[10]. Recognizing possible catatonia is vital, but reduced responsiveness can also indicate nonconvulsive seizures, medication side effects, or infection.

Because the sequence of these symptoms varies, your child’s care team will need to monitor their development closely to adjust therapies and treatments as their needs change. There is no universal schedule for monitoring (like serial EEGs or MRIs); testing should be symptom-driven.